A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

David Pierce,1 Mary Corcoran,2 Maria Velinova,3 Stuart Hossack,4 Mieke Hoppenbrouwers,5 Patrick Martin,21Shire, Basingstoke, UK; 2Shire, Wayne, PA, USA; 3PRA International, Zuidlaren, the Netherlands; 4Covance, Leeds, UK; 5Shire-Movetis NV, Turnhout, BelgiumBackground: About 30% of patients with ga...

Full description

Bibliographic Details
Main Authors: Pierce D, Corcoran M, Velinova M, Hossack S, Hoppenbrouwers M, Martin P
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/a-phase-1-randomized-study-evaluating-the-effect-of-omeprazole-on-the--peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/a-phase-1-randomized-study-evaluating-the-effect-of-omeprazole-on-the--peer-reviewed-article-DDDT

Similar Items